Tata Medical and Diagnostics has launched a new Covid-19 diagnostic test, reports LiveMint. The TataMD CHECK was developed through a collaboration between the Indian Council of Scientific and Industrial Research and the Institute of Genomics and Integrative Biology. The test can provide results within 90 minutes, with Tata’s plant in Chennai reportedly able to produce 1 million test kits a month.
Locally produced proteins in Brisbane are proving to be useful for detecting Covid-19. The University of Queensland’s Protein Expression Facility (PEF) has collaborated with the Public Health Virology team at Forensic and Scientific Services (FSS), to develop SARS-CoV-2 viral proteins. The proteins will be utilised in blood tests to screen antibodies for any prior exposure to Covid-19.
Clinical Reference Laboratory (CRL) has begun selling its CRL Rapid Response™ self-collected saliva test directly to consumers. The at-home saliva test is designed to be easy to use, and can delivers results onto users’ mobile phones through an authentication portal within 24 hours.
Centogene and Fujirebio Europe have collaborated to use LUMIPULSE® G technology for large-scale distribution of Covid-19 antigen testing. The tests will be further deployed at German airports, with Centogene having set up test centres at four of Germany’s largest airports in the last six months. Fujirebio is expected to supply Lumipulse G SARS-CoV-2 Ag assays on automated CLEIA-based LUMIPULSE G1200 instruments.